Institutional investors hold a majority ownership of VTRS through the 74.24% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended June 2019, these large investors purchased a net $1.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 3.6 Million shares of Viatris Inc
STATE STREET GLOBAL ADVISORS LTD... Bought 750.1 Thousand shares of Viatris Inc